Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Tsakonas

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Thoracic Disease|June 29, 2018
Oncogene-addicted non-small cell lung cancer and immunotherapyGeorgios Tsakonas, Simon Ekman
Lung Cancer (Amsterdam, Netherlands)|March 11, 2022
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case reportMarcus Skribek, Benedek Bozoky, Georgios Tsakonas
Clinical Lung Cancer|June 12, 2020
Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK InhibitionGeorgios Tsakonas, Vitali Grozman, Simon Ekman
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 24, 2010
Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stentingAthanasios Pipilis, George Lazaros, Georgios Tsakonas, et al.
Journal of Internal Medicine|January 15, 2022
Complications following novel therapies for non-small cell lung cancerMarcus Skribek, Konstantinos Rounis, Georgios Tsakonas, et al.
Cancers|March 28, 2026
Artificial Intelligence in <i>ALK</i>-Rearranged NSCLC: Forecasting Response and ResistanceAndreas Koulouris, Christos Tsagkaris, Konstantinos Kalaitzidis, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|January 17, 2008
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation chartsAthanasios Pipilis, Sotirios Kaliambakos, Christos Xenodochidis, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from SwedenSalomon Tendler, Vitali Grozman, Rolf Lewensohn, et al.
International Journal of Cancer|June 19, 2023
Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasisGeorgios Tsakonas, Simon Ekman, Andreas Koulouris, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Thoracic Disease|June 29, 2018
Oncogene-addicted non-small cell lung cancer and immunotherapyGeorgios Tsakonas, Simon Ekman
Lung Cancer (Amsterdam, Netherlands)|March 11, 2022
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case reportMarcus Skribek, Benedek Bozoky, Georgios Tsakonas
Clinical Lung Cancer|June 12, 2020
Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK InhibitionGeorgios Tsakonas, Vitali Grozman, Simon Ekman
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 24, 2010
Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stentingAthanasios Pipilis, George Lazaros, Georgios Tsakonas, et al.
Journal of Internal Medicine|January 15, 2022
Complications following novel therapies for non-small cell lung cancerMarcus Skribek, Konstantinos Rounis, Georgios Tsakonas, et al.
Cancers|March 28, 2026
Artificial Intelligence in <i>ALK</i>-Rearranged NSCLC: Forecasting Response and ResistanceAndreas Koulouris, Christos Tsagkaris, Konstantinos Kalaitzidis, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|January 17, 2008
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation chartsAthanasios Pipilis, Sotirios Kaliambakos, Christos Xenodochidis, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from SwedenSalomon Tendler, Vitali Grozman, Rolf Lewensohn, et al.
International Journal of Cancer|June 19, 2023
Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasisGeorgios Tsakonas, Simon Ekman, Andreas Koulouris, et al.
Pageof 5